top of page
  • LinkedIn
  • Facebook
  • Instagram
  • Twitter
  • YouTube
Vow launches cultured quail ‘foie gras,' becomes first company to sell multiple cultured meat products in various markets
Meat

Vow launches cultured quail ‘foie gras,' becomes first company to sell multiple cultured meat products in various markets

PoLoPo partners with CSM Ingredients to bring egg protein to baking market
Business

PoLoPo partners with CSM Ingredients to bring egg protein to baking market

Big Idea Ventures invests in six foodtech start-ups
Business

Big Idea Ventures invests in six foodtech start-ups

Massachusetts invests $2.1m to create new cell-ag centre at Tufts University
Business

Massachusetts invests $2.1m to create new cell-ag centre at Tufts University

Related posts

Jellatech has completed its new 9,000-square-foot facility in Morrisville, North Carolina, US, designed for ongoing research and development.


The US-based start-up uses cellular agriculture to produce animal-free, bio-identical proteins, including collagen and gelatin.


The facility, which is planned for Good Laboratory Practice (GLP) certification by 2026, marks a significant milestone in Jellatech’s mission to revolutionise the biotechnology landscape.


The new facility will enable Jellatech to scale-up its bio-identical collagen manufacturing capabilities, with a focus on validation and enabling customers to enter pre-clinical trials.


Equipped with advanced bioreactors and specialised labs, the facility enables Jellatech to accelerate the development of high-value proteins, optimise cell line development and meet stringent regulatory requirements in the biomedical and pharmaceutical industries.


The new space will enable Jellatech to:


🧬 Scale production of its bio-identical collagen for pre-clinical use

🧫 Advance cell line development for precision and consistency

🤝 Collaborate with industry partners on next-gen biostimulatory and regenerative health solutions


These efforts are crucial for establishing the groundwork needed for broad market adoption of collagen-based applications across various sectors.


Jellatech CEO Stephanie Michelsen said: “Our new facility represents a leap forward in our ability to deliver high-quality, consistent and ethically produced proteins for human health and longevity applications. This move not only significantly increases our production capacity but also reinforces our commitment to setting new standards in sustainability, innovation and cutting edge biotechnology.”


The facility will also serve as a hub for partnerships with industry leaders, enabling collaborative research and development aimed at advancing Jellatech’s solutions.


In July, Jellatech was selected to participate in the Bezos Earth Fund's new $30 million research centre at North Carolina State University.


#Jellatech #US #collagen

Jellatech opens new 9,000-square-foot US facility

Phoebe Fraser

6 November 2024

Jellatech opens new 9,000-square-foot US facility

bottom of page